Tenax Therapeutics (TENX) Receivables (2011 - 2018)
Tenax Therapeutics (TENX) posted quarterly Receivables of $39286.0 for Q2 2018, up 59.38% year-over-year from $24649.0 in Q2 2017, and little changed on a QoQ basis from $39286.0 in Q1 2018.
Tenax Therapeutics (TENX) Receivables (2011 - 2018) Analysis & Trends
Tenax Therapeutics has reported Receivables for 8 years, with the latest figure at $39286.0 in Q2 2018.
- Receivables for Q2 2018 came in at $39286.0, up 59.38% year-over-year; the trailing twelve-month figure through Jun 2018 was $39286.0 (up 59.38% YoY), and the FY2017 annual result was $50171.0, down 30.89% from the prior year.
- Receivables steadied at $39286.0 in Q2 2018, from $39286.0 in the prior quarter.
- Over five years, Receivables peaked at $113184.0 in Q1 2014 and troughed at $24648.0 in Q2 2016.
- A 5-year average of $49098.6 and a median of $39286.0 in 2018 frame the typical range for Receivables.
- The widest annual swing landed in 2014, when Receivables plunged 96.15%; it then jumped 110.34% in 2015.
- A 5-year view of Receivables shows it stood at $36358.0 in 2014, then surged by 36.0% to $49448.0 in 2015, then soared by 46.82% to $72599.0 in 2016, then plunged by 30.89% to $50171.0 in 2017, then declined by 21.7% to $39286.0 in 2018.
- Per Business Quant data, the three most recent Receivables figures were $39286.0 in Q2 2018, $39286.0 in Q1 2018, and $50171.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 39,286.00 |
| Mar 31, 2018 | 39,286.00 |
| Dec 31, 2017 | 50,171.00 |
| Sep 30, 2017 | 24,649.00 |
| Jun 30, 2017 | 24,649.00 |
| Mar 31, 2017 | 24,649.00 |
| Dec 31, 2016 | 72,599.00 |
| Sep 30, 2016 | 72,600.00 |
| Jun 30, 2016 | 24,648.00 |
| Mar 31, 2016 | 49,297.00 |
| Dec 31, 2015 | 49,448.00 |
| Apr 30, 2015 | 76,475.00 |
| Jan 31, 2015 | 64,662.00 |
| Jul 31, 2014 | 36,358.00 |
| Apr 30, 2014 | 36,358.00 |
| Jan 31, 2014 | 113,184.00 |
| Oct 31, 2013 | 59,058.00 |
| Jul 31, 2013 | 23,789.00 |
| Apr 30, 2013 | 945,237.00 |
| Jan 31, 2013 | 116,329.00 |